TY - JOUR T1 - MesobanK UK: an international mesothelioma bioresource JF - Thorax JO - Thorax SP - 380 LP - 382 DO - 10.1136/thoraxjnl-2015-207496 VL - 71 IS - 4 AU - Robert C Rintoul AU - Doris M Rassl AU - Jacki Gittins AU - Stefan J Marciniak Y1 - 2016/04/01 UR - http://thorax.bmj.com/content/71/4/380.abstract N2 - Malignant pleural mesothelioma causes the greatest societal burden of all the asbestos-related diseases. Progress in better understanding tumour biology will be facilitated by the availability of quality-assured annotated tissue. MesobanK has been created to establish a bioresource of pleural mesothelioma tissue linked to detailed anonymised clinical data. When complete, the bioresource will comprise a 750-patient tissue microarray and prospectively collected tissue, blood and pleural fluid from 300 patients with mesothelioma. Twenty-six new cell lines have also been developed. MesobanK meets all appropriate ethical and regulatory procedures and has recently opened to requests for tissue and data. ER -